RecruitingNot ApplicableNCT04760301
Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss
Local Tranexamic Acid During Vaginal Hysterectomy to Reduce Blood Loss
Sponsor
Meir Medical Center
Enrollment
60 participants
Start Date
Feb 16, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation
Eligibility
Sex: FEMALEMin Age: 20 YearsMax Age: 90 Years
Inclusion Criteria1
- -90 years old female patients going through vaginal hysterctomy
Exclusion Criteria4
- massive bleeding during operation due to major vessles injury
- known coagulopathies
- sensitivity to tranexamic acid
- medical need in tranexamic acid administration during operation due to bleeding
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGlocal tranexamic acid injection
local tranexamic acid injection to cervix- 1 g tranexamic acid diluted in 10 ml saline
OTHERlocal normal saline injection to cervix
local normal saline injection to the cervix- 20 ml saline
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04760301
Related Trials
Reducing Blood Loss During Myomectomy:Uterine Artery Ligation Vs Pericervical Tourniquet
NCT075263111 location
Oxytocin Pharmacokinetics and Pharmacodynamics
NCT054884572 locations
Transfusion Surveillance in Anaesthesia
NCT064031631 location
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
NCT068201772 locations
The Perioperative Outcome of Epinephrine Infusion and Tranexamic Acid in Knee Arthroplasty Surgery
NCT070892511 location